• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNektar Therapeutics
    Picture of Nektar Therapeutics logo

    NKTR — Nektar Therapeutics News Story

    $38.650.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    • Market Cap
      $1.32bn
    • Enterprise Value
      $692.66m
    • Revenue
      $55.23m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NKTR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NKTR Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Nektar Therapeutics logoNektar Therapeutics
    20/04/2026 14:00
    NASDAQ RESUMED  NKTR.O  AT 09:00 AM
    

    Recent news on Nektar Therapeutics

    See all news
    • Brief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      Yesterday 23:17
    • Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment

      01/10/2026 12:31
    • U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio

      25/09/2026 18:40
    • U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics

      25/09/2026 17:39
    • Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says

      25/09/2026 16:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.